Urease Enzyme: Structure, Function, and Its Role in Helicobacter pylori Pathogenesis and Treatment Strategies

Abstract

The metalloenzyme urease requires nickel as a cofactor to break down urea molecules, producing ammonia and carbon dioxide through hydrolysis. This biochemical process is fundamental to nitrogen cycling within soil ecosystems and various biological environments. Among disease-causing microorganisms, particularly Helicobacter pylori, this enzyme serves as a crucial pathogenic mechanism that allows bacterial survival within the harsh acidic conditions of gastric tissue. By generating ammonia, the organism effectively buffers stomach acid, establishing a protective alkaline microenvironment that supports bacterial colonization and long-term persistence. Such acid neutralization leads to gastric tissue irritation, inflammatory responses, and subsequent development of conditions including gastritis, ulcerative disease, and malignant gastric tumors. The enzyme's importance in H. pylori infection has made it valuable for clinical detection methods, including breath-based urea testing and rapid enzymatic assays. While conventional therapeutic approaches combine acid-suppressing medications with antimicrobial agents, increasing bacterial resistance to antibiotics has driven research into alternative strategies. Scientists are investigating both laboratory-synthesized and plant-derived urease inhibitors as supplementary treatment options. Current research examines urease's molecular architecture and catalytic mechanisms, its contribution to bacterial pathogenicity and survival, its utility in medical diagnostics, existing therapeutic protocols, and emerging possibilities for urease-targeting compounds, emphasizing recent scientific progress and future therapeutic development opportunities

Keywords: Urease, Helicobacter Pylori, Gastric Colonization, Urease Inhibitors, Pathogenesis, Natural Therapies, Antibiotic Resistance